What Are the Clinical Implications of RAD51D Mutations?
Identifying a mutation in the RAD51D gene has several clinical implications. For individuals with a known mutation, enhanced surveillance for ovarian and breast cancer is often recommended. Preventive options, such as prophylactic oophorectomy, may also be considered. Additionally, targeted therapies, like PARP inhibitors, have shown promise in treating cancers associated with homologous recombination deficiency.
